Description

ALPHA is a knowledge based, specialty pharmaceutical company.
It aims at developing differentiated products across a wide spectrum of therapeutic areas, by applying underlying rigorous scientific principles.
ALPHA serves the pharmaceutical needs of diverse markets worldwide through strong in-house R&D expertise in product development of complex drug molecules with specific emphasis in Oncology and Ophthalmology.
Developing complex Injectable such as lyophilized products, high potent drugs and long-acting products. Developed more than 35 Oncology Generics and specialty drugs. 40 dossiers have been filed across 25 countries of Emerging Market. 50+ generic dossiers been supported for filing with advanced markets covering wide therapeutic areas.

Company is looking for $4mn in debt to fuel its growth.

Posted Jul 31, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Suggested Searches

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.